Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.

Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.

老虎证券老虎证券2026/03/16 08:10
Show original
Meanwhile, the institution has set a target stock price of $330. This rating contrasts with the previous "buy" rating given by the institution, and the target price has also been significantly lowered from the previous high of $522 to $330. This adjustment reflects analysts' reassessment of the company's future prospects.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!